These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 15207894

  • 1. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J.
    Maturitas; 2004 Jul 15; 48(3):271-87. PubMed ID: 15207894
    [Abstract] [Full Text] [Related]

  • 2. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Jul 15; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Consequences of poor compliance with bisphosphonates.
    Briesacher BA, Andrade SE, Yood RA, Kahler KH.
    Bone; 2007 Nov 15; 41(5):882-7. PubMed ID: 17707710
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H.
    Curr Med Res Opin; 2007 Oct 15; 23(10):2517-29. PubMed ID: 17825128
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic therapy for the treatment and prevention of osteoporosis.
    McClung B, McClung M.
    Nurs Clin North Am; 2001 Sep 15; 36(3):433-40, viii. PubMed ID: 11532658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Compliance of osteoporotic patients with different treatment regimens.
    Segal E, Tamir A, Ish-Shalom S.
    Isr Med Assoc J; 2003 Dec 15; 5(12):859-62. PubMed ID: 14689753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potential clinical and economic impact of nonadherence with osteoporosis medications.
    Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY.
    Calcif Tissue Int; 2010 Mar 15; 86(3):202-10. PubMed ID: 20205345
    [Abstract] [Full Text] [Related]

  • 11. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA, Amonkar MM, Hebborn A, Altman R.
    Curr Med Res Opin; 2005 Sep 15; 21(9):1453-60. PubMed ID: 16197664
    [Abstract] [Full Text] [Related]

  • 12. Compliance with osteoporosis medications.
    Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA.
    Arch Intern Med; 2005 Nov 14; 165(20):2414-9. PubMed ID: 16287772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates.
    Danese MD, Badamgarav E, Bauer DC.
    J Bone Miner Res; 2009 Nov 14; 24(11):1819-26. PubMed ID: 19419313
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A, Lee E, Xue Z, Wutoh AK.
    Am J Geriatr Pharmacother; 2008 Dec 14; 6(5):240-8. PubMed ID: 19161926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of bisphosphonate therapy in a community setting.
    Feldstein AC, Weycker D, Nichols GA, Oster G, Rosales G, Boardman DL, Perrin N.
    Bone; 2009 Jan 14; 44(1):153-9. PubMed ID: 18926939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.